Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SUN, M.-S.
Right arrow Articles by ENDO, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SUN, M.-S.
Right arrow Articles by ENDO, F.
J Am Soc Nephrol 11:291-300, 2000
© 2000 American Society of Nephrology

A Mouse Model of Renal Tubular Injury of Tyrosinemia Type 1

Development of de Toni Fanconi Syndrome and Apoptosis of Renal Tubular Cells in Fah/Hpd Double Mutant Mice

MAO-SEN SUN*, SHINZABURO HATTORI{dagger}, SHUJI KUBO*, HISATAKA AWATA*, ICHIRO MATSUDA* and FUMIO ENDO*

* Department of Pediatrics, Kumamoto University School of Medicine, Kumamoto, Japan.
{dagger} The College of Medical Sciences, Kumamoto University School of Medicine, Kumamoto, Japan.

Correspondence to Dr. Fumio Endo, Department of Pediatrics, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan. Phone: +81 96 373 5188; Fax: +81 96 366 3471; E-mail: fendo{at}gpo.kumamoto-u.ac.jp

Hereditary tyrosinemia type 1 (HT1) (McKusick 276700), a severe autosomal recessive disorder of tyrosine metabolism, is caused by mutations in the fumarylacetoacetate hydrolase gene Fah (EC 3.7.1.2), which encodes the last enzyme in the tyrosine catabolic pathway. HT1 is characterized by severe progressive liver disease and renal tubular dysfunction. Homozygous disruption of the gene encoding Fah in mice causes neonatal lethality (e.g., lethal Albino deletion c14CoS mice), an event that limits use of this animal as a model for HT1. A new mouse model was developed with two genetic defects, Fah and 4-hydroxyphenylpyruvate dioxygenase (Hpd). The Fah-/- Hpd-/- mice grew normally without evidence of liver and renal disease, and the phenotype is similar to that in Fah+/+ Hpd-/- mice. The renal tubular cells of Fah-/- Hpd-/- mice, particularly proximal tubular cells, underwent rapid apoptosis when homogentisate, the intermediate metabolite between HPD and FAH, was administered to the Fah-/- Hpd-/- mice. Simultaneously, renal tubular function was impaired and Fanconi syndrome occurred. Apoptotic death of renal tubular cells, but not renal dysfunction, was prevented by pretreatment of the animals with YVAD, a specific inhibitor of caspases. In the homogentisate-treated Fah-/- Hpd-/- mice, massive amounts of succinylacetone were excreted into the urine, regardless of treatment with inhibitors. It is suggested that apoptotic death of renal tubular cells, as induced by administration of homogentisate to Fah-/- Hpd-/- mice, was caused by an intrinsic process, and that renal apoptosis and tubular dysfunctions in tubular cells occurred through different pathways. These observations shed light on the pathogenesis of renal tubular injury in subjects with FAH deficiency. These Fah-/- Hpd-/- mice can serve as a model in experiments related to renal tubular damage.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. L. Fisher, K. E. Page, G. J. Lithgow, and L. Nash
The Caenorhabditis elegans K10C2.4 Gene Encodes a Member of the Fumarylacetoacetate Hydrolase Family: A CAENORHABDITIS ELEGANS MODEL OF TYPE I TYROSINEMIA
J. Biol. Chem., April 4, 2008; 283(14): 9127 - 9135.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Nakamura, Y. Tanaka, H. Mitsubuchi, and F. Endo
Animal Models of Tyrosinemia
J. Nutr., June 1, 2007; 137(6): 1556S - 1560S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Endo, Y. Tanaka, K. Tomoeda, A. Tanoue, G. Tsujimoto, and K. Nakamura
Animal Models Reveal Pathophysiologies of Tyrosinemias
J. Nutr., June 1, 2003; 133(6): 2063S - 2067.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. R. Bandara, M. D. Kelly, E. A. Lock, and S. Kennedy
A Correlation between a Proteomic Evaluation and Conventional Measurements in the Assessment of Renal Proximal Tubular Toxicity
Toxicol. Sci., May 1, 2003; 73(1): 195 - 206.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP